GREY:BIOAF - Post by User
Comment by
prophetoffactzon Jan 18, 2023 7:08am
104 Views
Post# 35229940
RE:Sadly, I Think It's Checkmate
RE:Sadly, I Think It's Checkmate"However, there may be some upside to Biodexa and pursuing that may turn out to be good. If the stock has a run on news, and there could be some very strong news, then you might find an exit point, or good reason to continue to hold."
One billion shares but $10 tens-of-billions in potential revenue?
Early-stage biotech is incredibly risky but the market opportunities are there.
Biodexa could have two major plarform technologies validated by the world's largest healthcare company too. Both Q-Sphera and xB3 can work with already approved drugs. Midatech's lead cancer drug is also FDA approved and significantly de-risked for brain cancer in human clinical trials.
Like Midatech's CEO do you defy anyone to find a company this size with the opportunity set of Biodexa? Is there an indication a fund like Armitage Capital agrees? Ladenberg Thalmann? Is Biodexa a potential 'Saltarelli' on steroids?